nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

01.01.2004 | Concise Article

A Case of Multiorgan Failure Following Interruption of Antiretroviral Treatment

verfasst von: M. Crespo, J. C. Paradiñeiro, E. Ribera, I. Ruiz, V. Falcó, J. Lopez-Quiñones, I. Ocaña, A. Pahissa

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 1/2004

Einloggen, um Zugang zu erhalten

Abstract

Reported here is an exceptional case of acute retroviral syndrome resembling septic shock that occurred in a chronic HIV-infected patient shortly following planned interruption of antiretroviral treatment. The therapeutic strategy, which is aimed at improving the immunological control of HIV infection, can therefore be deleterious in chronically infected patients and should be avoided outside of closely monitored clinical trials.

Lori F, Foli A, Lisziewiz J (2002) Structured treatment interruptions as a potential alternative therapeutic regimen for HIV-infected patients: a review of recent clinical data and future prospects. J Antimicrob Chemother 50:155–160CrossRefPubMed

Palella F, Delaney K, Moorman A, et al (1998) Declining morbidity and mortality among patients with advanced HIV infection. N Engl J Med 338:853–860PubMed

Carcelain G, Tubiana R, Samri A, Calvez V, Delaugerre C, Agut H, Katlama C, Autran B (2000) Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection. J Virol 75:234–241CrossRef

Chun TW, Stuyver L, Mizell SB, Ehler L, Mican JO, Baseler M, Lloyd A, Nowak M, Fauci A (1997) Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci 94:13193–13197CrossRefPubMed

Harrigan PR, Whaley M, Montaner J (1999) Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy. AIDS 13:F59–F62CrossRefPubMed

Frost S, Martinez-Picado J, Ruiz L, Clotet B, Leight Brown A (2002) Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection. J Virol 76:968–979PubMed

Hoen B, Burgard M, Fournier I, Lacabaratz C, Raffi F, Lafauri M, Livrozet JM, Rouzioux C, Venet A, Aboulker JP (2001) Structured treatment interruptions (STI) in acute seroconverters: interim results of the multicenter prospective PRIMSTOP pilot trial (ANRS 100). 9^th Conference on Retroviruses and Retroviral Infection. Abstract 530

Walensky RP, Goldie SJ, Sax PE, Weinstein MC, Paltiel AD, Kimmel AD, Seage GR, Losina E, Zhang H, Islam R, Freedberg KA (2000) Treatment of primary HIV infection: projecting outcomes of immediate, interrupted or delayed therapy. J Acquir Immune Defic Syndr 31:27–37

Hirschel B, Fagard C, Oxenius A, Gunthard H, Garcia F (2001) SSITT: a prospective trial of treatment interruptions in HIV infection. 9^th Conference on Retroviruses and Retroviral Infection. Abstract 528

10.

Oxenius A, Price DA, Gunthar HF, Dawson SJ, Fagard C, Perrin L, Fischer M, Weber R, Plana M, Garcia F, Hirschel B, Mclean A, Phillips RE (2002) Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhace viral control in chronic infection. Proc Natl Acad Sci USA 99:13747–13752CrossRef

11.

Lawrence J, Mayers D, Hupler K, Collins G, Abrams D, Reisler R, Crane L, Shmetter B, Dionne T, Saldanha J, Jones M, Baxter J (2003) A randomised trial examining structured treatment interruption for patients failing therapy with multi-drug resistant HIV. In: Program and abstracts, 10^th Conference on Retroviruses and Retroviral Infection. Oral abstract no. 67

12.

Katlama C, Dominguez S, Duvivier C, Delaugerre C, Peytavin G, Legrad M, Calvez V, Gourlain K, Costagliola D (2003) Long-term benefit of treatment interruption in salvage therapy. In: Program and abstracts, 10^th Conference on Retroviruses and Retroviral Infection. Oral abstract no. 68

13.

Kahn J, Walker B (1998) Acute human immunodeficiency virus type 1 infection. N Engl J Med 339:33–39PubMed

14.

Eerens F, Van Cleemput J, Petermans WE (1999) A probable primary HIV infection associated with acute non-specific myocarditis causing severe dilated cardiomyopathy. Acta Clin Belg 54:220–222PubMed

15.

Schindler JM, Neftel KA (1990) Simultaneous primary infection with HIV and CMV leading to severe pancytopenia, hepatitis, nephritis, perimyocarditis, myosisits, and alopecia totalis. Klin Wochenschr 68:237–240PubMed

16.

Pitcher CJ, Quittner C, Peterson DM, Connor M, Koup R, Maino V, Picker LJ (1999) HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med 5:1518–1525CrossRef

17.

Currie PF, Boon NA (2003) Immunopathogenesis of HIV-related heart muscle disease: current perspectives. AIDS 17 (Suppl 1):21–28

18.

Moroni M, Antinori S (2003) HIV direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era. AIDS 17 (Suppl 1):51–64

19.

Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA (2003) Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42:466–472CrossRefPubMed

20.

Falcó V, Crespo M, Ribera E (2003) Lactic acidosis related to nucleoside therapy in HIV-infected patients. Expert Opin Pharmacother 4:1321–1329PubMed

Titel: A Case of Multiorgan Failure Following Interruption of Antiretroviral Treatment
verfasst von: M. Crespo
J. C. Paradiñeiro
E. Ribera
I. Ruiz
V. Falcó
J. Lopez-Quiñones
I. Ocaña
A. Pahissa
Publikationsdatum: 01.01.2004
Verlag: Springer-Verlag
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 1/2004
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-003-1049-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

A Case of Multiorgan Failure Following Interruption of Antiretroviral Treatment

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Blutdrucksenkung könnte Uterusmyome verhindern

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Update Innere Medizin

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2004

Use of Direct Latex Agglutination Testing of Selective Broth in the Detection of Group B Strepptococcal Carriage in Pregnant Women

January 2004

Haemophilus parainfluenzae: an Underdiagnosed Pathogen of Biliary Tract Infections?

Two Cases of Systemic Candida glabrata Infection Following In Vitro Fertilization and Embryo Transfer

Sepsis with Bullous Necrotizing Skin Lesions due to Vibrio vulnificus Acquired Through Recreational Activities in the Baltic Sea

In Vitro Susceptibility of Nocardia Species to Cethromycin, Clarithromycin and Amikacin

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Blutdrucksenkung könnte Uterusmyome verhindern

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Update Innere Medizin